アレルギー性鼻炎治療薬の世界市場レポート 2025年

アレルギー性鼻炎治療薬の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.5％で196億1,000万米ドルに成長します。予測期間の成長は、呼吸器疾患の増加、環境汚染の増加、気候条件の変化、アレルギーに苦しむ個人の増加、アレルギー反応と利用可能な治療法に関する意識の高まりと相まって、汚染レベルが高まっていることに起因しています。予測期間の主な動向としては、治療法の技術開発、新しい抗ヒスタミン薬の開発、アレルギー鼻炎診断の技術進歩、アレルギー治療分野の進歩、新しい治療法の研究開発の増加などが挙げられます。

呼吸器疾患の発生率の増加は、アレルギー性鼻炎治療薬市場の成長を促進すると予想されます。呼吸器疾患には、肺や気道に影響を及ぼすさまざまな疾患が含まれます。この増加は、気候変動や呼吸器感染症の有病率の上昇とともに、大気汚染やアレルゲンなどの環境汚染物質にさらされる機会が増えていることが主な原因です。アレルギー性鼻炎治療薬は、炎症を抑え、鼻づまりやくしゃみなどの症状を緩和し、呼吸機能を改善するため、これらの疾患の管理に極めて重要です。例えば、2024年4月、米国の政府機関である疾病対策予防センターは、現在喘息を患っている成人の割合が、2021年の8.0％から2023年には8.9％に増加したと報告しました。その結果、呼吸器疾患の有病率の増加がアレルギー性鼻炎薬市場の成長を促進しています。

アレルギー性鼻炎治療薬市場の主要企業は、免疫反応を効果的に高めてアレルギー症状を緩和するために、新規プロバイオティクスなどの革新的ソリューションの開発に注力しています。これらの新規プロバイオティクスは、免疫系を調整し、アレルギー性鼻炎の症状を軽減する可能性について研究されています。バランスのとれた腸内細菌叢をサポートすることで、従来の治療に代わる有望な自然療法となります。例えば、2024年3月、インドの製薬会社Entod Pharma社は、アレルギー性鼻炎を含む鼻アレルギーを管理するためのラクトシールドRHを発表しました。この製品は、腸内細菌叢を安定させ、免疫反応を調整するよう設計された臨床試験済みのプロバイオティクス菌株を特徴としており、鼻アレルギーの症状を緩和する可能性があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界アレルギー性鼻炎治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のアレルギー性鼻炎治療薬市場：成長率分析
• 世界のアレルギー性鼻炎治療薬市場の実績：規模と成長, 2019-2024
• 世界のアレルギー性鼻炎治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界アレルギー性鼻炎治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアレルギー性鼻炎治療薬市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 季節性アレルギー性鼻炎
• 通年性アレルギー性鼻炎
• 職業性アレルギー性鼻炎
• 世界のアレルギー性鼻炎治療薬市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• 免疫療法
• コルチコステロイド
• 鼻づまり解消薬
• その他の治療法
• 世界のアレルギー性鼻炎治療薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 鼻腔
• 眼内
• 静脈内
• 世界のアレルギー性鼻炎治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小売薬局
• 病院薬局
• オンラインチャンネル
• 世界のアレルギー性鼻炎治療薬市場季節性アレルギー性鼻炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 花粉症
• 花粉アレルギー
• 春と夏のアレルギー
• 世界のアレルギー性鼻炎治療薬市場通年性アレルギー性鼻炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ダニアレルギー
• ペットのフケアレルギー
• カビアレルギー
• 世界のアレルギー性鼻炎治療薬市場職業性アレルギー性鼻炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学物質曝露アレルギー
• 職業性粉塵・煙アレルギー
• 特定の職場環境に関連するアレルギー

第7章 地域別・国別分析

• 世界のアレルギー性鼻炎治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアレルギー性鼻炎治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アレルギー性鼻炎治療薬市場：競合情勢
• アレルギー性鼻炎治療薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline PLC
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• Sun Pharmaceuticals Industries Ltd.
• Perrigo Company plc
• Dr. Reddy's Laboratories
• Apotex Inc.
• Meda AB
• Amneal Pharmaceuticals Inc.
• Glenmark Pharmaceuticals Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アレルギー性鼻炎治療薬市場2029：新たな機会を提供する国
• アレルギー性鼻炎治療薬市場2029：新たな機会を提供するセグメント
• アレルギー性鼻炎治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Allergic rhinitis drugs are medications used to alleviate symptoms of allergic rhinitis, a condition marked by inflammation of the nasal passages due to allergens such as pollen, dust, mold, or animal dander. These drugs help relieve symptoms such as sneezing, itching, nasal congestion, and a runny nose.

The main types of allergic rhinitis covered by these drugs include seasonal allergic rhinitis, perennial allergic rhinitis, and occupational allergic rhinitis. Seasonal allergic rhinitis, often referred to as hay fever, occurs at specific times of the year when allergens such as pollen from trees, grasses, or weeds are prevalent. Treatments for allergic rhinitis include antihistamines, immunotherapy, corticosteroids, decongestants, and other medications. These treatments can be administered through various routes, including oral, nasal, intraocular, and intravenous methods. They are distributed through channels such as retail pharmacies, hospital pharmacies, and online platforms.

The allergic rhinitis drugs market research report is one of a series of new reports from The Business Research Company that provides allergic rhinitis drugs market statistics, including allergic rhinitis drugs industry global market size, regional shares, competitors with an allergic rhinitis drugs market share, detailed allergic rhinitis drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the allergic rhinitis drugs industry. This allergic rhinitis drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The allergic rhinitis drugs market size has grown steadily in recent years. It will grow from $15.67 billion in 2024 to $16.42 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to rising awareness about allergic reactions and available treatment modes, increasing prevalence of allergic rhinitis, heightened demand for effective drugs, and the popularity of over-the-counter (OTC) allergy medications.

The allergic rhinitis drugs market size is expected to see steady growth in the next few years. It will grow to $19.61 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to growing pollution levels coupled with a rise in respiratory disorders, increasing environmental pollution, changing climatic conditions, a rise in the number of individuals suffering from allergies, and rising awareness about allergic reactions and available treatment modes. Major trends in the forecast period include technological developments in treatment methods, the development of new antihistamines, technological advances in allergy rhinitis diagnostics, advancements in the field of allergy treatment, increase in research and development of new therapies.

The increasing incidence of respiratory disorders is expected to drive the growth of the allergic rhinitis drug market. Respiratory disorders include a variety of conditions that impact the lungs and airways. This rise is largely attributed to greater exposure to environmental pollutants, such as air pollution and allergens, along with climate change and a higher prevalence of respiratory infections. Allergic rhinitis drugs are crucial for managing these disorders, as they reduce inflammation and alleviate symptoms such as nasal congestion and sneezing, thus improving respiratory function. For example, in April 2024, the Centers for Disease Control and Prevention, a US-based governmental body, reported that the percentage of adults with current asthma increased from 8.0% in 2021 to 8.9% in 2023. Consequently, the growing prevalence of respiratory disorders is fueling the growth of the allergic rhinitis drug market.

Leading companies in the Allergic Rhinitis Drugs market are focusing on developing innovative solutions, such as novel probiotics, to effectively enhance immune responses and alleviate allergy symptoms. These novel probiotics are being studied for their potential to regulate the immune system and reduce symptoms of allergic rhinitis. By supporting a balanced gut microbiome, they present a promising natural alternative to conventional treatments. For example, in March 2024, Entod Pharma, a pharmaceutical company based in India, introduced Lactoshield RH for managing nasal allergies, including allergic rhinitis. This product features clinically tested probiotic strains designed to stabilize gut flora and modulate immune responses, potentially easing symptoms of nasal allergies.

In January 2022, Glenmark Pharmaceuticals Limited formed a partnership with Lotus Pharmaceutical Co. Ltd. to extend the market reach of Ryaltris into Singapore, Hong Kong, and Vietnam. This collaboration allows Glenmark to utilize Lotus's established network in Southeast Asia for the introduction of Ryaltris, while Lotus will manage commercialization, pending regulatory approvals to ensure compliance and facilitate market entry. Lotus Pharmaceutical Co. Ltd. is a Taiwan-based pharmaceutical company.

Major companies operating in the allergic rhinitis drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Sun Pharmaceuticals Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories, Apotex Inc., Meda AB, Amneal Pharmaceuticals Inc., Glenmark Pharmaceuticals Ltd, ALK-Abello A/S, Stallergenes Greer plc, Himalaya Wellness Company, Unichem Laboratories Limited, Aytu BioPharma Inc., Allergy Therapeutics PLC, DMK Pharmaceuticals Corporation, Revolo Biotherapeutics

Asia-Pacific was the largest region in the allergic rhinitis drugs market in 2024. The regions covered in the allergic rhinitis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the allergic rhinitis drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The allergic rhinitis drugs market consists of sales of mast cell stabilizers, drops, and saline nasal sprays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Allergic Rhinitis Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allergic rhinitis drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for allergic rhinitis drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The allergic rhinitis drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis; Occupational Allergic Rhinitis
• 2) By Treatment: Antihistamines; Immunotherapy; Corticosteroids; Decongestants; Other Treatments
• 3) By Route Of Administration: Oral; Nasal; Intraocular; Intravenous
• 4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Channel
• Subsegments:
• 1) By Seasonal Allergic Rhinitis: Hay Fever; Pollen Allergy; Spring And Summer Allergies
• 2) By Perennial Allergic Rhinitis: Dust Mite Allergy; Pet Dander Allergy; Mold Allergy
• 3) By Occupational Allergic Rhinitis: Chemical Exposure Allergies; Occupational Dust And Fume Allergies; Allergies Related To Specific Work Environments
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co.; Bayer AG; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Allergic Rhinitis Drugs Market Characteristics

3. Allergic Rhinitis Drugs Market Trends And Strategies

4. Allergic Rhinitis Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Allergic Rhinitis Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Allergic Rhinitis Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Allergic Rhinitis Drugs Market Growth Rate Analysis
• 5.4. Global Allergic Rhinitis Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Allergic Rhinitis Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Allergic Rhinitis Drugs Total Addressable Market (TAM)

6. Allergic Rhinitis Drugs Market Segmentation

• 6.1. Global Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Seasonal Allergic Rhinitis
• Perennial Allergic Rhinitis
• Occupational Allergic Rhinitis
• 6.2. Global Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Immunotherapy
• Corticosteroids
• Decongestants
• Other Treatments
• 6.3. Global Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Nasal
• Intraocular
• Intravenous
• 6.4. Global Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Pharmacies
• Hospital Pharmacies
• Online Channel
• 6.5. Global Allergic Rhinitis Drugs Market, Sub-Segmentation Of Seasonal Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hay Fever
• Pollen Allergy
• Spring And Summer Allergies
• 6.6. Global Allergic Rhinitis Drugs Market, Sub-Segmentation Of Perennial Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dust Mite Allergy
• Pet Dander Allergy
• Mold Allergy
• 6.7. Global Allergic Rhinitis Drugs Market, Sub-Segmentation Of Occupational Allergic Rhinitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemical Exposure Allergies
• Occupational Dust And Fume Allergies
• Allergies Related To Specific Work Environments

7. Allergic Rhinitis Drugs Market Regional And Country Analysis

• 7.1. Global Allergic Rhinitis Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Allergic Rhinitis Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Allergic Rhinitis Drugs Market

• 8.1. Asia-Pacific Allergic Rhinitis Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Allergic Rhinitis Drugs Market

• 9.1. China Allergic Rhinitis Drugs Market Overview
• 9.2. China Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Allergic Rhinitis Drugs Market

• 10.1. India Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Allergic Rhinitis Drugs Market

• 11.1. Japan Allergic Rhinitis Drugs Market Overview
• 11.2. Japan Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Allergic Rhinitis Drugs Market

• 12.1. Australia Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Allergic Rhinitis Drugs Market

• 13.1. Indonesia Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Allergic Rhinitis Drugs Market

• 14.1. South Korea Allergic Rhinitis Drugs Market Overview
• 14.2. South Korea Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Allergic Rhinitis Drugs Market

• 15.1. Western Europe Allergic Rhinitis Drugs Market Overview
• 15.2. Western Europe Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Allergic Rhinitis Drugs Market

• 16.1. UK Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Allergic Rhinitis Drugs Market

• 17.1. Germany Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Allergic Rhinitis Drugs Market

• 18.1. France Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Allergic Rhinitis Drugs Market

• 19.1. Italy Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Allergic Rhinitis Drugs Market

• 20.1. Spain Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Allergic Rhinitis Drugs Market

• 21.1. Eastern Europe Allergic Rhinitis Drugs Market Overview
• 21.2. Eastern Europe Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Allergic Rhinitis Drugs Market

• 22.1. Russia Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Allergic Rhinitis Drugs Market

• 23.1. North America Allergic Rhinitis Drugs Market Overview
• 23.2. North America Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Allergic Rhinitis Drugs Market

• 24.1. USA Allergic Rhinitis Drugs Market Overview
• 24.2. USA Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Allergic Rhinitis Drugs Market

• 25.1. Canada Allergic Rhinitis Drugs Market Overview
• 25.2. Canada Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Allergic Rhinitis Drugs Market

• 26.1. South America Allergic Rhinitis Drugs Market Overview
• 26.2. South America Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Allergic Rhinitis Drugs Market

• 27.1. Brazil Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Allergic Rhinitis Drugs Market

• 28.1. Middle East Allergic Rhinitis Drugs Market Overview
• 28.2. Middle East Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Allergic Rhinitis Drugs Market

• 29.1. Africa Allergic Rhinitis Drugs Market Overview
• 29.2. Africa Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Allergic Rhinitis Drugs Market Competitive Landscape And Company Profiles

• 30.1. Allergic Rhinitis Drugs Market Competitive Landscape
• 30.2. Allergic Rhinitis Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Allergic Rhinitis Drugs Market Other Major And Innovative Companies

• 31.1. AstraZeneca plc
• 31.2. Novartis AG
• 31.3. GlaxoSmithKline PLC
• 31.4. Boehringer Ingelheim International GmbH
• 31.5. Viatris Inc.
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Regeneron Pharmaceuticals Inc.
• 31.8. Bausch Health Companies Inc.
• 31.9. Sun Pharmaceuticals Industries Ltd.
• 31.10. Perrigo Company plc
• 31.11. Dr. Reddy's Laboratories
• 31.12. Apotex Inc.
• 31.13. Meda AB
• 31.14. Amneal Pharmaceuticals Inc.
• 31.15. Glenmark Pharmaceuticals Ltd

32. Global Allergic Rhinitis Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Allergic Rhinitis Drugs Market

34. Recent Developments In The Allergic Rhinitis Drugs Market

35. Allergic Rhinitis Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Allergic Rhinitis Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Allergic Rhinitis Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Allergic Rhinitis Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer